バスキュラーアクセスデバイス市場：タイプ別（中枢（末梢、トンネル型、非トンネル型、埋め込みポート）、末梢（ショート、正中線、翼状））、用途別（薬剤、血液、流体、診断）、エンドユーザー別（病院、診療所、外来）、地域別 - 2028年までの世界予測

Vascular Access Device Market by Type (Central (Peripheral, Tunneled, Non- tunneled, Implanted Ports), Peripheral (Short, Midline, Winged)), Application (Drug, Blood, Fluid, Diagnostic), End User (Hospitals, Clinics, Ambulatory) &Region - Global Forecast to 2028

世界の血管アクセス装置市場は、2023年の56億米ドルから2028年には79億米ドルに達し、予測期間中の年平均成長率は7.0％と予測されている。バスキュラーアクセスデバイス市場の成長は主に、生活習慣病の流行、化学... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年8月2日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	188	167	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

世界の血管アクセス装置市場は、2023年の56億米ドルから2028年には79億米ドルに達し、予測期間中の年平均成長率は7.0％と予測されている。バスキュラーアクセスデバイス市場の成長は主に、生活習慣病の流行、化学療法処置の増加、小児患者におけるバスキュラーアクセスデバイス使用の増加といった要因に起因している。しかし、バスキュラーアクセスデバイスの設置やメンテナンスにかかるコストが高いため、予測期間中のバスキュラーアクセスデバイス市場の成長はある程度制限されると予想される。

2023年には、中央血管アクセス装置分野が血管アクセス装置市場で最大のシェアを占めると予測されている。

血管アクセス装置市場は、タイプ別に末梢アクセス装置、中央血管アクセス装置、アクセサリーに区分され、アクセサリーが大きな割合を占めている。2023年には、中央血管アクセス装置分野が世界の血管アクセス装置市場で最大のシェアを占めると予測されている。中央バスキュラーアクセスデバイスは、化学療法や心血管障害、慢性腎臓病の治療で広く使用されている。

薬剤投与は、2023年に血管アクセス装置市場で最大のシェアを占めると予測されている。

用途別では、血管アクセス装置市場は薬剤投与、輸液・栄養投与、輸血、診断・検査に区分される。特に感染症や癌の治療のための薬剤投与に血管アクセスデバイスが多く使用されていることなどが市場成長を促進している。

エンドユーザー別では、病院が2022年に最大シェアを占める
エンドユーザー別では、バスキュラーアクセスデバイス市場は、病院、診療所・外来センター、その他のエンドユーザー（介護施設、研究所、診断・画像診断センター、在宅医療機関）に区分される。2022年には、病院が最大の市場シェアを占めた。血管処置の大半が病院で行われ、また病院での救急医療では輸血や様々な薬剤投与のために補助人工心臓が必要とされるためである。

地域別では、北米がバスキュラーアクセスデバイス市場で最大のシェアを占めると予測されている。
地域別では、2023年に北米が血管アクセス装置市場で最大のシェアを占めた。主要プレイヤーの存在、支援的な償還の枠組み、最先端医療機器への政府の多額の投資、医療費の上昇、政府の取り組み、可処分所得の増加などの要因が、北米の市場成長に寄与している。

主要参入企業の内訳は以下の通り：
- 企業タイプ別：Tier 1-55%、Tier 2-25%、Tier 3-20
- 役職別 - Cレベル-43%、ディレクターレベル-32%、その他-25
- 地域別 - 北米-38%、欧州-23%、アジア太平洋地域-29%、その他の地域-10

血管アクセス装置市場の主要企業
同市場の主なプレーヤーは、Becton, Dickinson and Company（米国）、ICU Medical, Inc.（米国）、Teleflex Incorporated（米国）、B. Braun SE（ドイツ）、AngioDynamics, Inc.(米国）、テルモ（日本）、ニプロメディカル（日本）、メドトロニック（アイルランド）、アメカス（エジプト）、ロムソンズ（インド）、PRODIMED（フランス）、クックメディカル（米国）、アクセスバスキュラー（米国）、メディカルコンポーネンツ（米国）、Vygon（フランス）、3M（米国）、アルゴンメディカルデバイス（米国）、Guangdong Baihe Medical Technology Co、Ltd.（中国(Ltd.（中国）、pfm medical（ドイツ）、Medi-Tech Devices Pvt Ltd（インド）、Medline Industries, LP（米国）、Kimal（英国）、Deltamed（イタリア）、Newtech Medical Devices（インド）、Shanghai Puyi Medical Instruments Co.）

調査範囲
この調査レポートは、血管アクセス装置市場を分析し、タイプ、用途、エンドユーザーなどの様々なセグメントに基づいて、市場規模や今後の成長可能性を推定することを目的としています。また、市場で入手可能な様々な血管アクセス装置製品の製品ポートフォリオマトリックスも掲載しています。また、同市場における主要企業の競合分析も行っており、企業プロフィール、サービス内容、主要な市場戦略などを掲載しています。
レポート購入の理由
本レポートは、既存企業だけでなく、新規参入企業や小規模企業にとっても、市場の動向を把握する上で有益であり、ひいては市場シェアを拡大する上で役立ちます。本レポートを購入される企業は、以下の戦略のいずれか、または任意の組み合わせを使用して、市場での地位を強化することができます。

本レポートは、以下のポイントに関する洞察を提供する：
血管アクセス装置市場の成長に影響を与える主な促進要因（生活習慣病有病率の増加、化学療法処置数の増加、小児患者における血管アクセス装置の使用増加）、阻害要因（血管アクセス装置の設置およびメンテナンスに関わる高コスト、製品リコールおよび故障）、機会（技術の進歩および病院数の増加）、課題（熟練した専門家の不足および血管アクセス装置に関連するリスク）の分析。

- 市場への浸透：世界の血管アクセス装置市場におけるトップ企業が提供する製品ポートフォリオに関する包括的な情報を掲載しています。本レポートでは、この市場をタイプ別、用途別、エンドユーザー別に分析しています。
- サービスの強化/革新：血管アクセス装置の世界市場における今後の動向に関する詳細な洞察
- 市場開発：用途別、タイプ別、エンドユーザー別の有利な新興市場に関する包括的情報。
- 市場の多様化：血管アクセス装置の世界市場における新サービスやサービス強化、成長地域、最新動向、投資に関する詳細情報
- 競合評価：血管アクセス装置の世界市場における主要企業の市場シェア、成長戦略、製品・サービス内容、企業評価象限、能力などを詳細に評価します。

ページTOPに戻る

1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.2.1 INCLUSIONS & EXCLUSIONS 26
1.2.2 MARKETS COVERED 26
FIGURE 1 VASCULAR ACCESS DEVICES MARKET SEGMENTATION 26
1.2.3 REGIONAL SEGMENTATION 27
1.2.4 YEARS CONSIDERED 27
1.3 CURRENCY 27
1.4 STAKEHOLDERS 28
1.5 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
FIGURE 2 RESEARCH DESIGN 29
2.1.1 SECONDARY DATA 30
2.1.1.1 Key data from secondary sources 31
2.1.2 PRIMARY DATA 31
FIGURE 3 PRIMARY SOURCES 32
2.1.2.1 Key data from primary sources 33
2.1.2.2 Key industry insights 33
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS 34
2.2 MARKET SIZE ESTIMATION 34
FIGURE 5 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 35
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: BECTON, DICKINSON AND COMPANY 35
FIGURE 7 SEGMENTAL EXTRAPOLATION: GLOBAL VASCULAR ACCESS DEVICES MARKET (2022) 36
FIGURE 8 BOTTOM-UP APPROACH: GLOBAL VASCULAR ACCESS DEVICES MARKET (2022) 37
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38
FIGURE 10 CAGR PROJECTIONS 38
FIGURE 11 TOP-DOWN APPROACH 39
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 40
FIGURE 12 DATA TRIANGULATION METHODOLOGY 40
2.4 STUDY ASSUMPTIONS 41
2.5 LIMITATIONS 41
2.5.1 METHODOLOGY-RELATED LIMITATIONS 41
2.6 RISK ASSESSMENT 41
2.7 VASCULAR ACCESS DEVICES MARKET: RECESSION IMPACT 41
3 EXECUTIVE SUMMARY 43
FIGURE 13 VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 43
FIGURE 14 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 44
FIGURE 15 VASCULAR ACCESS DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 44
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF VASCULAR ACCESS DEVICES MARKET 45
4 PREMIUM INSIGHTS 46
4.1 VASCULAR ACCESS DEVICES MARKET OVERVIEW 46
FIGURE 17 GROWING PREVALENCE OF LIFESTYLE DISEASES TO DRIVE MARKET GROWTH 46
4.2 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER 47
FIGURE 18 HOSPITALS ACCOUNTED FOR LARGEST SHARE OF APAC MARKET IN 2022 47
4.3 VASCULAR ACCESS DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 48
FIGURE 19 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 48
4.4 REGIONAL MIX: VASCULAR ACCESS DEVICES MARKET (2021–2028) 49
FIGURE 20 ASIA PACIFIC MARKET TO GROW AT HIGHEST RATE DURING FORECAST PERIOD 49
4.5 VASCULAR ACCESS DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES 49
FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 49
5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
5.2 MARKET DYNAMICS 50
FIGURE 22 VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
5.2.1 DRIVERS 51
5.2.1.1 Growing prevalence of lifestyle diseases 51
5.2.1.2 Increasing number of chemotherapy procedures 51
5.2.1.3 Growing use of vascular access devices in pediatric patients 52
5.2.2 RESTRAINTS 52
5.2.2.1 High cost associated with placement and maintenance of vascular access devices 52
5.2.2.2 Product recalls and failures 52
5.2.3 OPPORTUNITIES 53
5.2.3.1 Technological advancements 53
5.2.3.2 Growth in number of hospitals 54
5.2.4 CHALLENGES 54
5.2.4.1 Shortage of skilled professionals 54
5.2.4.2 Risks associated with vascular access devices 54
5.3 INDUSTRY TRENDS 55
5.3.1 MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES 55
5.3.2 INNOVATIONS IN CATHETER MATERIALS AND COATINGS 55
5.4 VALUE CHAIN ANALYSIS 56
FIGURE 23 MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 56
5.5 ECOSYSTEM MAPPING 57
5.5.1 ROLE IN ECOSYSTEM 57
5.6 PORTER’S FIVE FORCES ANALYSIS 58
5.6.1 THREAT OF NEW ENTRANTS 58
5.6.2 INTENSITY OF COMPETITIVE RIVALRY 58
5.6.3 BARGAINING POWER OF BUYERS 58
5.6.4 BARGAINING POWER OF SUPPLIERS 58
5.6.5 THREAT OF SUBSTITUTES 58
6 VASCULAR ACCESS DEVICES MARKET, BY TYPE 59
6.1 INTRODUCTION 60
TABLE 1 VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 60
6.2 CENTRAL VASCULAR ACCESS DEVICES 60
TABLE 2 CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 61
TABLE 3 CENTRAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 61
6.2.1 PERIPHERALLY INSERTED CENTRAL CATHETERS 62
6.2.1.1 Complications associated with PICCs to limit adoption in coming years 62
TABLE 4 PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 62
6.2.2 TUNNELED CATHETERS 63
6.2.2.1 Advantages of tunneled catheters such as lower risk of infection and lower chances of accidental removal to boost demand 63
TABLE 5 TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 63
6.2.3 NON-TUNNELED CATHETERS 64
6.2.3.1 High risk of infection to limit market growth 64
TABLE 6 NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 64
6.2.4 IMPLANTED PORTS 65
6.2.4.1 Lowest risk of infection associated with implanted ports to support growth 65
TABLE 7 IMPLANTED PORTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 65
6.3 PERIPHERAL VASCULAR ACCESS DEVICES 66
TABLE 8 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 66
TABLE 9 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 67
6.3.1 PERIPHERAL SHORT DEVICES 67
6.3.1.1 Ability of peripheral short devices to only administer select types of medication to hamper growth 67
TABLE 10 PERIPHERAL SHORT DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 68
6.3.2 PERIPHERAL MIDLINE DEVICES 68
6.3.2.1 Need for trained nurses for procedures to restrict growth 68
TABLE 11 PERIPHERAL MIDLINE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 69
6.3.3 BUTTERFLY/WINGED STEEL NEEDLES 69
6.3.3.1 Wide usage of winged steel needles in blood sampling and diagnosis to propel growth 69
TABLE 12 BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 70
6.4 ACCESSORIES 70
6.4.1 RECURRENT NEED FOR ACCESSORIES TO BOOST MARKET 70
TABLE 13 VASCULAR ACCESS DEVICE ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 71
7 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 72
7.1 INTRODUCTION 73
TABLE 14 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 73
7.2 DRUG ADMINISTRATION 73
7.2.1 HIGH USAGE OF VASCULAR ACCESS DEVICES FOR DRUG ADMINISTRATION TO BOOST SEGMENTAL GROWTH 73
TABLE 15 VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 74
7.3 FLUID & NUTRITION ADMINISTRATION 74
7.3.1 GROWING USE OF PERIPHERAL VASCULAR ACCESS DEVICES FOR SHORT-TERM NUTRITIONAL THERAPY TO SUPPORT MARKET 74
TABLE 16 VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 75
7.4 BLOOD TRANSFUSION 75
7.4.1 FREQUENT NEED FOR BLOOD TRANSFUSION IN TREATMENT OF VARIOUS CONDITIONS TO BOOST GROWTH 75
TABLE 17 VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 76
7.5 DIAGNOSTICS & TESTING 76
7.5.1 GROWING POPULARITY OF PERIPHERAL LINES FOR DIAGNOSTIC & TESTING APPLICATIONS TO DRIVE MARKET GROWTH 76
TABLE 18 VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 77
8 VASCULAR ACCESS DEVICES MARKET, BY END USER 78
8.1 INTRODUCTION 79
TABLE 19 VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 79
8.2 HOSPITALS 79
8.2.1 HIGH DEMAND FOR VASCULAR ACCESS DEVICES IN HOSPITAL SETTINGS TO BOOST MARKET 79
TABLE 20 VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 80
8.3 CLINICS & AMBULATORY CARE CENTERS 80
8.3.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO SUPPORT MARKET GROWTH 80
TABLE 21 VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 81
8.4 OTHER END USERS 81
TABLE 22 VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 82
9 VASCULAR ACCESS DEVICES MARKET, BY REGION 83
9.1 INTRODUCTION 84
TABLE 23 VASCULAR ACCESS DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 84
9.2 NORTH AMERICA 84
9.2.1 NORTH AMERICA: RECESSION IMPACT 84
FIGURE 24 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET SNAPSHOT 85
TABLE 24 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 25 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 86
TABLE 26 NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 86
TABLE 27 NORTH AMERICA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 87
TABLE 28 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 87
TABLE 29 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 87
9.2.2 US 88
9.2.2.1 High prevalence of chronic diseases to drive market growth 88
TABLE 30 INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED 88
TABLE 31 US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 89
TABLE 32 US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 89
TABLE 33 US: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 89
TABLE 34 US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 90
TABLE 35 US: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 90
9.2.3 CANADA 90
9.2.3.1 Increasing number of minimally invasive procedures to support market growth 90
TABLE 36 CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 91
TABLE 37 CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 91
TABLE 38 CANADA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 92
TABLE 39 CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 92
TABLE 40 CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 92
9.3 EUROPE 93
9.3.1 EUROPE: RECESSION IMPACT 93
TABLE 41 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 42 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 94
TABLE 43 EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 94
TABLE 44 EUROPE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 94
TABLE 45 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 95
TABLE 46 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 95
9.3.2 GERMANY 95
9.3.2.1 Growing geriatric and obese populations to contribute to market growth 95
TABLE 47 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 96
TABLE 48 GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 96
TABLE 49 GERMANY: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 97
TABLE 50 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 97
TABLE 51 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 97
9.3.3 UK 98
9.3.3.1 Increasing incidence of coronary heart disease to support market growth 98
TABLE 52 UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 98
TABLE 53 UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 99
TABLE 54 UK: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 99
TABLE 55 UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 99
TABLE 56 UK: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 100
9.3.4 FRANCE 100
9.3.4.1 Strong government support and favorable strategies & initiatives to drive market growth 100
TABLE 57 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 100
TABLE 58 FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 101
TABLE 59 FRANCE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 101
TABLE 60 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 102
TABLE 61 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 102
9.3.5 ITALY 102
9.3.5.1 Strong healthcare policies by government to propel growth 102
TABLE 62 ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 63 ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 64 ITALY: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 104
TABLE 65 ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 104
TABLE 66 ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 104
9.3.6 SPAIN 105
9.3.6.1 Growing geriatric population to increase demand for vascular access devices 105
TABLE 67 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 68 SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 69 SPAIN: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 70 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 106
TABLE 71 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 106
9.3.7 REST OF EUROPE 107
TABLE 72 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 107
TABLE 73 REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
TABLE 74 REST OF EUROPE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
TABLE 75 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 109
TABLE 76 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 109
9.4 ASIA PACIFIC 109
9.4.1 ASIA PACIFIC: RECESSION IMPACT 110
FIGURE 25 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET SNAPSHOT 111
TABLE 77 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 78 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
TABLE 79 ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
TABLE 80 ASIA PACIFIC: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 113
TABLE 81 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 113
TABLE 82 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 113
9.4.2 JAPAN 114
9.4.2.1 Large geriatric population to support market growth 114
TABLE 83 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 114
TABLE 84 JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 115
TABLE 85 JAPAN: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 115
TABLE 86 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 116
TABLE 87 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 116
9.4.3 CHINA 116
9.4.3.1 Growing target patient population to drive market growth 116
TABLE 88 CHINA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 117
TABLE 89 CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 117
TABLE 90 CHINA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
TABLE 91 CHINA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 118
TABLE 92 CHINA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 118
9.4.4 INDIA 119
9.4.4.1 Increasing prevalence of diabetes to drive adoption of vascular access devices 119
TABLE 93 INDIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 119
TABLE 94 INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 120
TABLE 95 INDIA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 120
TABLE 96 INDIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 121
TABLE 97 INDIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 121
9.4.5 REST OF ASIA PACIFIC 121
TABLE 98 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 99 REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 100 REST OF ASIA PACIFIC: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 101 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 123
TABLE 102 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 123
9.5 REST OF THE WORLD 124
9.5.1 REST OF THE WORLD: RECESSION IMPACT 124
TABLE 103 REST OF THE WORLD: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 104 REST OF THE WORLD: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 105 REST OF THE WORLD: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 106 REST OF THE WORLD: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 126
TABLE 107 REST OF THE WORLD: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 126
10 COMPETITIVE LANDSCAPE 127
10.1 OVERVIEW 127
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 127
TABLE 108 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS 127
10.3 REVENUE SHARE ANALYSIS 130
FIGURE 26 REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2020–2022) 130
10.4 MARKET SHARE ANALYSIS 130
FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2022) 131
10.5 MARKET RANKING ANALYSIS 131
FIGURE 28 VASCULAR ACCESS DEVICES MARKET: KEY PLAYER RANKING, 2022 132
10.6 COMPANY EVALUATION MATRIX 133
10.6.1 STARS 133
10.6.2 EMERGING LEADERS 133
10.6.3 PERVASIVE PLAYERS 133
10.6.4 PARTICIPANTS 133
FIGURE 29 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 134
10.7 COMPANY EVALUATION MATRIX FOR SMES/START-UPS 135
10.7.1 PROGRESSIVE COMPANIES 135
10.7.2 DYNAMIC COMPANIES 135
10.7.3 STARTING BLOCKS 135
10.7.4 RESPONSIVE COMPANIES 135
FIGURE 30 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS (2022) 136
10.8 COMPANY FOOTPRINT ANALYSIS 137
TABLE 109 COMPANY FOOTPRINT: VASCULAR ACCESS DEVICES MARKET (2022) 137
10.8.1 COMPANY FOOTPRINT, BY TYPE 138
TABLE 110 TYPE FOOTPRINT: VASCULAR ACCESS DEVICES MARKET (2022) 138
10.8.2 COMPANY FOOTPRINT, BY REGION 139
TABLE 111 REGIONAL FOOTPRINT: VASCULAR ACCESS DEVICES MARKET (2022) 139
10.9 COMPETITIVE SCENARIO 140
10.9.1 PRODUCT LAUNCHES 140
TABLE 112 PRODUCT LAUNCHES, JANUARY 2019–JULY 2023 140
10.9.2 DEALS 141
TABLE 113 DEALS, JANUARY 2019–JULY 2023 141
10.9.3 OTHER DEVELOPMENTS 142
TABLE 114 OTHER DEVELOPMENTS, JANUARY 2019–JULY 2023 142
11 COMPANY PROFILES 143
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
11.1 KEY PLAYERS 143
11.1.1 BECTON, DICKINSON AND COMPANY 143
TABLE 115 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 143
FIGURE 31 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 144
11.1.2 TELEFLEX INCORPORATED 148
TABLE 116 TELEFLEX INCORPORATED: BUSINESS OVERVIEW 148
FIGURE 32 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022) 149
11.1.3 ICU MEDICAL, INC. 152
TABLE 117 ICU MEDICAL, INC.: BUSINESS OVERVIEW 152
FIGURE 33 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2022) 153
11.1.4 B. BRAUN SE 156
TABLE 118 B. BRAUN SE: BUSINESS OVERVIEW 156
FIGURE 34 B. BRAUN SE: COMPANY SNAPSHOT (2022) 157
11.1.5 ANGIODYNAMICS, INC. 160
TABLE 119 ANGIODYNAMICS, INC.: BUSINESS OVERVIEW 160
FIGURE 35 ANGIODYNAMICS, INC.: COMPANY SNAPSHOT (2022) 161
11.1.6 TERUMO CORPORATION 163
TABLE 120 TERUMO CORPORATION: BUSINESS OVERVIEW 163
FIGURE 36 TERUMO CORPORATION: COMPANY SNAPSHOT (2023) 164
11.1.7 NIPRO MEDICAL CORPORATION 165
TABLE 121 NIPRO MEDICAL CORPORATION: BUSINESS OVERVIEW 165
FIGURE 37 NIPRO MEDICAL CORPORATION: COMPANY SNAPSHOT (2022) 165
11.1.8 MEDTRONIC 167
TABLE 122 MEDTRONIC: BUSINESS OVERVIEW 167
FIGURE 38 MEDTRONIC: COMPANY SNAPSHOT (2022) 168
11.1.9 AMECATH 170
TABLE 123 AMECATH: BUSINESS OVERVIEW 170
11.1.10 ROMSONS 172
TABLE 124 ROMSONS: BUSINESS OVERVIEW 172
11.1.11 PRODIMED 173
TABLE 125 PRODIMED: BUSINESS OVERVIEW 173
11.1.12 COOK MEDICAL 174
TABLE 126 COOK MEDICAL: BUSINESS OVERVIEW 174
11.1.13 ACCESS VASCULAR, INC. 175
TABLE 127 ACCESS VASCULAR, INC.: BUSINESS OVERVIEW 175
11.1.14 MEDICAL COMPONENTS, INC. 176
TABLE 128 MEDICAL COMPONENTS, INC.: BUSINESS OVERVIEW 176
11.1.15 VYGON 178
TABLE 129 VYGON: BUSINESS OVERVIEW 178
11.2 OTHER COMPANIES 180
11.2.1 3M 180
11.2.2 ARGON MEDICAL DEVICES 181
11.2.3 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD. 181
11.2.4 PFM MEDICAL 182
11.2.5 MEDI-TECH DEVICES PVT. LTD. 183
11.2.6 MEDLINE INDUSTRIES, LP 183
11.2.7 KIMAL 184
11.2.8 DELTA MED 184
11.2.9 NEWTECH MEDICAL DEVICES 185
11.2.10 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD. 185
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

12 APPENDIX 186
12.1 DISCUSSION GUIDE 186
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 190
12.3 CUSTOMIZATION OPTIONS 192
12.4 RELATED REPORTS 192
12.5 AUTHOR DETAILS 193

ページTOPに戻る

Table of Contents

Summary

The global vascular access device market is projected to reach USD 7.9 billion by 2028 from USD 5.6 billion in 2023, at a CAGR of 7.0% during the forecast period. Growth in the vascular access device market can primarily be attributed to factors such as the growing prevalence of lifestyle diseases, increasing number of chemotherapy procedures, and growing use of vascular access device in pediatric patients. However, the high cost involved in the placement and maintenance of vascular access device is expected to limit the growth of the vascular access device market to a certain extent during the forecast period.

In 2023, the central vascular access device segment is projected to account for the largest share of the vascular access device market

By type, vascular access device market is segmented into there are peripheral access device, central vascular access device, and accessories holding a significant portion. The central vascular access device segment is is projected to account for the largest share of the global vascular access device market in 2023. Factors such as broad usage of central vascular access device in chemotherapy and in the medication of cardiovascular disorders and chronic kidney disorders.

Drug administration is projected to account for the largest share of the vascular access device market in 2023

By application, vascular access device market is segmented into drug administration, fluid and nutrition administration,blood transfusion, and diagnostic & testing. The drug administration segment is is projected to account for the largest share of the global vascular access device market in 2023.Factors such as high use of vascular access device for drug administration, specially for the treatment of infections and cancer are driving the market growth.

By end user, hospitals accounted for the largest share of the market in 2022
By end users, vascular access device market is segmented into hospitals, clinics & ambulatory centers, and other end users (nursing homes, laboratories, diagnostic & imaging centers, and home healthcare agencies). In 2022, hospitals accounted for the largest market share. Factors suc as majority of vascular procedures are performed in hospital settings and also emergency care in hospitals needs VADs for blood transfusion and administration of various drugs.

By region, North America is projected to account for the largest share of the vascular access device market
By region,North America accounted for the largest share of the vascular access device market in 2023. Factors such as the presence of key players, a supportive reimbursement framework, and significant government investments in cutting-edge medical devices,rising healthcare costs, government initiatives, and an increase in disposable income are contributing to the market's growth in North America.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–55%, Tier 2–25%, and Tier 3–20%
• By Designation – C-level–43%, Director-level–32%, Others–25%
• By Region – North America–38%, Europe–23%, Asia Pacific–29%, Rest of the World- 10%

Key players in the vascular access device Market
The prominent players in this market are Becton, Dickinson and Company (US), ICU Medical, Inc. (US), Teleflex Incorporated (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Terumo Corporation (Japan), Nipro Medical Corporation (Japan), Medtronic (Ireland), Amecath (Egypt),Romsons (India), PRODIMED (France),Cook Medical (US), Access Vascular, Inc. (US), Medical Components, Inc. (US), Vygon (France), 3M (US), Argon Medical Devices (US), Guangdong Baihe Medical Technology Co., Ltd. (China), pfm medical (Germany), Medi-Tech Devices Pvt Ltd (India), Medline Industries, LP (US), Kimal (UK), Deltamed (Italy), Newtech Medical Devices (India) and Shanghai Puyi Medical Instruments Co., Ltd (China).

Research Coverage:
The report analyzes the vascular access device Market and aims at estimating the market size and future growth potential of this market based on various segments such as type, application and end user. The report also includes a product portfolio matrix of various vascular access device products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
Analysis of key drivers (growing prevalence of lifestyle diseases,increasing number of chemotherapy procedures,increasing use of vascular access device in pediatric patients), restraints (high costs involved in the placement and maintenance of vascular access device,product recalls and failures), opportunities (technological advancements and growth in the number of hospitals) and challenges (Shortage of skilled professionals and risks associated with vascular access device) influencing the growth of vascular access device market.

• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global vascular access device Market. The report analyzes this market by type, applications and end user.
• Service Enhancement/Innovation: Detailed insights on upcoming trends in the global vascular access device Market
• Market Development: Comprehensive information on the lucrative emerging markets by applications, type and end user.
• Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global vascular access device Market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, company evaluation quadrant, and capabilities of leading players in the global vascular access device Market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート

本レポートと同じKEY WORD（blood）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療機器）の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート

本レポートと同じKEY WORD（blood）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?